#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	12276	16S	1529	1529	99.93	16S.l15.c17.ctg.1	1976	608.8	0	.	n	.	0	A69G	SNP	69	69	A	270	270	G	652	G,A	625,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	12276	16S	1529	1529	99.93	16S.l15.c17.ctg.1	1976	608.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1385	1385	C	671	C	645	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23286	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3545	648.6	0	.	n	.	0	T695C	SNP	695	695	T	1033	1033	C	708	C	682	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23286	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3545	648.6	0	.	n	.	0	G1337A	SNP	1337	1337	G	1675	1675	A	758	A,G	733,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23286	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3545	648.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2309	2309	C	690	C,T	659,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23286	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3545	648.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2383	2383	A	693	A	674	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23286	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3545	648.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2935	2935	C	643	C	625	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1532	folP	855	855	100.0	folP.l15.c30.ctg.1	1519	98.7	1	SNP	p	R229S	1	.	.	685	687	AGC	1011	1013	AGC	154;155;154	A;G;C	153;153;151	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4538	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3544	126.3	1	SNP	p	S91F	1	.	.	271	273	TTC	651	653	TTC	150;149;151	T;T;C	146;148;149	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4538	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3544	126.3	1	SNP	p	G95N	0	.	.	283	285	GGC	663	665	GGC	150;151;151	G;G,A;C	143;144,1;148	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4538	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3544	126.3	1	SNP	p	D95G	1	.	.	283	285	GGC	663	665	GGC	150;151;151	G;G,A;C	143;144,1;148	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1324	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1448	90.3	1	SNP	p	G45D	0	.	.	133	135	GGC	511	513	GGC	173;171;175	G;G;C	165;164;168	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	664	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1134	58.1	0	.	n	.	0	A197.	DEL	197	197	A	569	569	A	157	A	153	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3808	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2895	129.6	1	SNP	p	D86N	0	.	.	256	258	GAC	503	505	GAC	154;155;154	G;A;C	148;144;146	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3808	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2895	129.6	1	SNP	p	R87I	0	.	.	259	261	CGT	506	508	CGT	157;157;157	C;G;T	150;150;148	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3808	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2895	129.6	1	SNP	p	R87W	0	.	.	259	261	CGT	506	508	CGT	157;157;157	C;G;T	150;150;148	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3808	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2895	129.6	1	SNP	p	S87R	1	.	.	259	261	CGT	506	508	CGT	157;157;157	C;G;T	150;150;148	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3808	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2895	129.6	1	SNP	p	S88P	0	.	.	262	264	TCC	509	511	TCC	157;160;161	T;C;C	150;150;149	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3286	parE	1986	1986	100.0	parE.l15.c17.ctg.1	2587	125.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1563	1565	GGC	178;177;173	G;G;C	170;170;166	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	3210	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2552	124.3	1	SNP	p	A311V	0	.	.	931	933	GCA	1333	1335	GCA	183;183;179	G;C;A	171;171;167	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3210	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2552	124.3	1	SNP	p	I312M	0	.	.	934	936	ATC	1336	1338	ATC	180;179;177	A;T;C	167;167;169	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3210	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2552	124.3	1	SNP	p	V316P	0	.	.	946	948	GTG	1348	1350	GTG	173;172;172	G;T;G	161;160;158	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3210	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2552	124.3	1	SNP	p	V316T	0	.	.	946	948	GTG	1348	1350	GTG	173;172;172	G;T;G	161;160;158	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3210	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2552	124.3	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1852	1854	ACC	127;127;127	A;C;C	117;117;122	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3210	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2552	124.3	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1906	1908	GCG	139;140;144	G;C;G	129;122;132	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3210	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2552	124.3	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1906	1908	GCG	139;140;144	G;C;G	129;122;132	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3210	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2552	124.3	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2029	2031	AGC	129;126;129	A;G;C	125;121;125	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3210	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2552	124.3	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2038	2040	GGC	135;134;132	G;G;C	129;127;124	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3210	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2552	124.3	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2056	2058	CCG	101;106;106	C,G;C,G;G,C	86,3;93,2;84,1	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4736	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	3010	154.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1548	1550	CCG	175;174;173	C;C;G	165;168;164	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1934	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1913	99.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	591	591	C	129	C	123	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2300	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1749	129.3	0	.	p	.	0	N38E	NONSYN	112	114	AAT	561	563	GAA	185;181;182	G;A;A	183;177;180	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2300	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1749	129.3	0	.	p	.	0	N134D	NONSYN	400	402	AAT	849	851	GAT	146;146;146	G;A;T	145;145;143	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2300	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1749	129.3	0	.	p	.	0	P175S	NONSYN	523	525	CCA	972	974	TCA	181;180;181	T;C;A	170;170;172	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2300	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1749	129.3	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1101	1103	GTC	206;205;204	G;T;C	196;189;197	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2300	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1749	129.3	0	.	p	.	0	F222S	NONSYN	664	666	TTT	1113	1115	TCT	202;206;203	T,G;C,T;T	196,1;202,1;200	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2300	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1749	129.3	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1431	1433	GCA	188;188;186	G;C,A;A	182;181,1;179	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2300	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1749	129.3	1	SNP	p	G120K	1	.	.	358	360	AAG	807	809	AAG	143;142;140	A;A;G	133;132;130	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2300	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1749	129.3	1	SNP	p	A121D	1	.	.	361	363	GAC	810	812	GAC	141;139;140	G;A;C	132;130;132	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2300	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1749	129.3	1	SNP	p	D121N	0	.	.	361	363	GAC	810	812	GAC	141;139;140	G;A;C	132;130;132	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	8138	rpoB	4179	4179	99.98	rpoB.l6.c30.ctg.1	4802	167.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	920	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1041	87.0	1	SNP	p	V57M	1	.	.	169	171	ATG	510	512	ATG	184;184;184	A;T;G	181;181;182	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
